Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protective role of the matricellular protein CCN3 in abdominal aortic aneurysm.

Literature DB >> 27746977

Protective role of the matricellular protein CCN3 in abdominal aortic aneurysm.

Pavel Uhrin¹, Johannes M Breuss¹.

Abstract

Entities: Disease Gene

Year: 2016 PMID： 27746977 PMCID： PMC5059237 DOI： 10.21037/jtd.2016.09.21

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

24 in total

1. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury.

Authors: P D Ellis; Q Chen; P J Barker; J C Metcalfe; P R Kemp
Journal: Arterioscler Thromb Vasc Biol Date: 2000-08 Impact factor: 8.311

Review 2. Angiotensin II receptors in endothelial cells.

Authors: M E Pueyo; J B Michel
Journal: Gen Pharmacol Date: 1997-11

3. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.

Authors: Cristiane G Lin; Chih-Chiun Chen; Shr-Jeng Leu; Tatiana M Grzeszkiewicz; Lester F Lau
Journal: J Biol Chem Date: 2004-12-20 Impact factor: 5.157

Review 4. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies.

Authors: Frank M Davis; Debra L Rateri; Alan Daugherty
Journal: Heart Date: 2014-07-24 Impact factor: 5.994

5. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.

Authors: Tatsushi Shimoyama; Shûichi Hiraoka; Minoru Takemoto; Masaya Koshizaka; Hirotake Tokuyama; Takahiko Tokuyama; Aki Watanabe; Masaki Fujimoto; Harukiyo Kawamura; Seiya Sato; Yuya Tsurutani; Yasushi Saito; Bernard Perbal; Haruhiko Koseki; Koutaro Yokote
Journal: Arterioscler Thromb Vasc Biol Date: 2010-02-05 Impact factor: 8.311

6. CCN notch signaling in vascular smooth muscle cells: good or bad?

Authors: Jun-ichi Abe; Chen Yan
Journal: Arterioscler Thromb Vasc Biol Date: 2010-04 Impact factor: 8.311

7. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.

Authors: R Pyo; J K Lee; J M Shipley; J A Curci; D Mao; S J Ziporin; T L Ennis; S D Shapiro; R M Senior; R W Thompson
Journal: J Clin Invest Date: 2000-06 Impact factor: 14.808

Protective role of the matricellular protein CCN3 in abdominal aortic aneurysm.

1. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury.

Review 2. Angiotensin II receptors in endothelial cells.

3. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.

Review 4. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies.

5. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.

6. CCN notch signaling in vascular smooth muscle cells: good or bad?

7. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.

8. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.

Review 9. The Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and Treatment.

10. NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells.

1. NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway.